BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with FDA's Overreach on Compounded Peptides BPC 157 FDA approval status 2026: Is it legal? Veedma Dr Jesse Morse explains why BPC 157 will never receive FDA approval despite its potential to accelerate healing and recovery from injuries. >> More The Sikiric Problem: One Lab, Thirty Years, Zero Trials That Matter